Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.

× No keyword cloud information.

8 in total

Review 1. A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors: R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal: Expert Rev Clin Pharmacol Date: 2013-05 Impact factor: 5.045

Review 2. A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors: Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal: J Med Toxicol Date: 2015-09

Review 3. Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences.

Authors: Alice Tseng; Christine A Hughes; Janet Wu; Jason Seet; Elizabeth J Phillips
Journal: Ann Pharmacother Date: 2017-06-19 Impact factor: 3.154

4. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir.

Authors: Valerie A Gruber; Petrie M Rainey; David E Moody; Gene D Morse; Qing Ma; Sudha Prathikanti; Patricia A Pade; Anika A H Alvanzo; Elinore F McCance-Katz
Journal: Clin Infect Dis Date: 2011-11-18 Impact factor: 9.079

5. Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Authors: Alice Tseng; Michelle Foisy
Journal: Curr Infect Dis Rep Date: 2012-02 Impact factor: 3.725

6. Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapy.

Authors: Xia Luo; Jose Trevejo; Rolf P G van Heeswijk; Frances Smith; Varun Garg
Journal: Antimicrob Agents Chemother Date: 2012-05-07 Impact factor: 5.191

Review 7. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors: Nina Y Yuan; Marcus Kaul
Journal: J Neuroimmune Pharmacol Date: 2019-08-06 Impact factor: 4.147

Review 8. Polypharmacy in the HIV-infected older adult population.

Authors: Lauren J Gleason; Amneris E Luque; Krupa Shah
Journal: Clin Interv Aging Date: 2013-06-21 Impact factor: 4.458

8 in total